AIFF

Announcements

Nothing here yet

Daily updates

• Firefly Neuroscience partnered with NeuroSigma to integrate the FDA-cleared Monarch eTNS non-pharmacological ADHD treatment into its Evoke provider network.Sep 25, 2026

FDA designations

Nothing here yet

News

• Firefly and NeuroSigma partner to expand access to the first FDA-cleared non-drug treatment for pediatric ADHDSep 26, 2026
• Firefly Neuroscience’s Evoke platform was selected to provide objective brain-function insights for Radial’s AI-native operating system for brain medicineSep 17, 2026
• Firefly Neuroscience and Next Health launch a precision cognitive health initiative following supportive FDA advisory committee recommendationsJul 28, 2026
• Firefly signs new commercial agreement for use of its FDA-cleared BNA™ platform in precision neuroscience researchJul 14, 2025